Studies: Adding ketamine does not help cancer pain

10/16/2012 | Medscape (free registration)

A late-stage clinical trial found that adding subcutaneous ketamine to opioids and standard coanalgesics did not improve control of cancer pain compared with a placebo, Flinders University researchers told a palliative care conference. The incidence of worsening adverse events, however, was nearly doubled among patients using ketamine compared with the placebo.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI